keyword
Keywords Gastrointestinal neuroendocrin...

Gastrointestinal neuroendocrine tumors

https://read.qxmd.com/read/38693425/surgical-resection-of-double-advanced-pancreatic-neuroendocrine-tumors-with-multiple-renal-cell-carcinoma-associated-with-von-hippel-lindau-disease
#1
JOURNAL ARTICLE
Yoshiyuki Shibata, Takeshi Sudo, Sho Tazuma, Takashi Onoe, Atsushi Yamaguchi, Masanobu Shigeta, Kazuya Kuraoka, Rie Yamamoto, Shinya Takahashi, Hirotaka Tashiro
Von Hippel-Lindau (VHL) disease, an autosomal dominant genetic disorder caused by a germline mutation, is associated with non-functional and slow-growing pancreatic neuroendocrine tumor (PNET) and kidney cancer. We describe the case of a 46 year-old man with a 35 mm mass in the pancreatic head causing stricture of the bile duct and main pancreatic duct, a 55 mm mass in the pancreatic tail causing obstruction of the splenic vein (SV), and multiple masses of > 36 mm on both kidneys...
May 2, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38690053/blastomas-of-the-digestive-system-in-adults-a-review
#2
REVIEW
Yu Liu, Tony El Jabbour, Jonathan Somma, Yukihiro Nakanishi, Saverio Ligato, Hwajeong Lee, Zhi-Yan Fu
Blastomas, characterized by a mixture of mesenchymal, epithelial, and undifferentiated blastematous components, are rare malignant neoplasms originating from precursor blast cells. This review focuses on digestive system blastomas in adult patients, including gastroblastoma, hepatoblastoma, and pancreatoblastoma. Gastroblastoma is a biphasic, epitheliomesenchymal tumor, with only sixteen cases reported to date. In addition to the characteristic histology, metastasis-associated lung adenocarcinoma transcript 1 - glioma-associated oncogene homolog 1 gene fusion is typical, although recently novel ewing sarcoma breakpoint region 1 - c-terminal binding protein 1 and patched 1 - glioma-associated oncogene homolog 2 fusions have been described...
April 27, 2024: World Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38689806/mr-imaging-findings-of-primary-ovarian-carcinoid-a-novel-finding-of-t1-hyperintense-solid-tissue
#3
Shinya Fujii, Chie Inoue, Hiroto Yunaga, Takuro Gonda, Jun Makishima, Ryoya Ochiai, Daisuke Yamaji, Kanae Ozaki
Ovarian carcinoid is a rare well-differentiated neuroendocrine tumor resembling those arising in the gastrointestinal tract. We present a case of ovarian carcinoid with magnetic resonance imaging (MRI) findings. A 50-year-old woman with genital bleeding and severe constipation was referred to our hospital. On MR imaging, a left ovarian tumor showed iso to high signal intensity on T1-weighted images (T1WI), relatively low signal intensity on T2WI, and slightly high signal intensity on diffusion-weighted images...
July 2024: Radiology Case Reports
https://read.qxmd.com/read/38688415/tumor-microenvironment-and-immune-response-a-gateway-to-novel-therapies-in-gastrointestinal-cancers
#4
JOURNAL ARTICLE
Damian Jacenik
No abstract text is available yet for this article.
April 28, 2024: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38687646/a-rare-case-of-metastatic-poorly-differentiated-neuroendocrine-tumor-arising-from-the-sigmoid-colon-in-an-active-duty-service-member
#5
JOURNAL ARTICLE
Casey Arnold, Erin K Hourigan, Wu Shudee, Sherry Jilinksi, Allison Bush, Amber Feinman, Amie Harvey
Neuroendocrine tumors (NET) are rare malignancies that contain neural and endocrine cells with a median age of diagnosis of 63 years. NETs are typically located in the gastrointestinal (GI) tract, the pancreas, or the lungs. Within the GI tract, the most common locations for NETs are the small bowel, appendix, or rectum. They are often asymptomatic and found incidentally on imaging or during procedures. NETs arising from the left side of the colon are very uncommon. While most NETs are well-differentiated by histology and are slow growing, 7% are poorly differentiated and usually progress rapidly...
April 30, 2024: Military Medicine
https://read.qxmd.com/read/38685134/critical-updates-in-neuroendocrine-tumors-version-9-american-joint-committee-on-cancer-staging-system-for-gastroenteropancreatic-neuroendocrine-tumors
#6
JOURNAL ARTICLE
Aman Chauhan, Kelley Chan, Thorvardur R Halfdanarson, Andrew M Bellizzi, Guido Rindi, Dermot O'Toole, Phillip S Ge, Dhanpat Jain, Arvind Dasari, Daniel A Anaya, Emily Bergsland, Erik Mittra, Alice C Wei, Thomas A Hope, Ayse T Kendi, Samantha M Thomas, Sherlonda Flem, James Brierley, Elliot A Asare, Kay Washington, Chanjuan Shi
The American Joint Committee on Cancer (AJCC) staging system for all cancer sites, including gastroenteropancreatic neuroendocrine tumors (GEP-NETs), is meant to be dynamic, requiring periodic updates to optimize AJCC staging definitions. This entails the collaboration of experts charged with evaluating new evidence that supports changes to each staging system. GEP-NETs are the second most prevalent neoplasm of gastrointestinal origin after colorectal cancer. Since publication of the AJCC eighth edition, the World Health Organization has updated the classification and separates grade 3 GEP-NETs from poorly differentiated neuroendocrine carcinoma...
April 29, 2024: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/38678248/a-rare-case-of-neuroendocrine-cell-tumor-mixed-with-a-mucinous-component-in-the-ampulla-of-vater
#7
JOURNAL ARTICLE
Tamotus Sugai, Noriyuki Uesugi, Masamichi Suzuki, Nobuyasu Suzuki, Michitaka Honda, Tsuyoshi Abe, Naoki Yanagawa
BACKGROUND: A rare case of neuroendocrine cell tumor (NET) having both conventional and mucinous components was reported. Mucinous NET is rarely encountered in the pathological diagnosis of gastrointestinal (GI) tumors. Here we examined the mechanism for transformation of conventional NETs into mucinous NETs. CASE PRESENTATION: Macroscopic examination revealed a tumor with ulceration in the ampulla of Vater that measured 1.7 cm in its largest diameter. Histologically, the tumor comprised two components: a tubular/ribbon-like feature and small nests floating in a mucinous lake...
April 27, 2024: Diagnostic Pathology
https://read.qxmd.com/read/38658858/gut-microbiota-composition-and-metabolic-characteristics-in-patients-with-craniopharyngioma
#8
JOURNAL ARTICLE
Chunhui Liu, Fangzheng Liu, Ding Nie, Youchao Xiao, Wentao Wu, Yanfei Jia, Lu Jin, Ning Qiao, Kefan Cai, Siming Ru, Xin Liu, Yifan Song, Jintian Xu, Lei Cao, Songbai Gui
BACKGROUND: Emerging evidence suggests that the gut microbiota is associated with various intracranial neoplastic diseases. It has been observed that alterations in the gut microbiota are present in gliomas, meningiomas, and pituitary neuroendocrine tumors (Pit-NETs). However, the correlation between gut microbiota and craniopharyngioma (CP), a rare embryonic malformation tumor in the sellar region, has not been previously mentioned. Consequently, this study aimed to investigate the gut microbiota composition and metabolic patterns in CP patients, with the goal of identifying potential therapeutic approaches...
April 25, 2024: BMC Cancer
https://read.qxmd.com/read/38657156/diagnostic-anatomic-imaging-for-neuroendocrine-neoplasms-maximizing-strengths-and-mitigating-weaknesses
#9
JOURNAL ARTICLE
Mina Hesami, Michael Blake, Mark A Anderson, Luigi Asmundo, Aoife Kilcoyne, Zahra Najmi, Peter D Caravan, Ciprian Catana, Cynthia Czawlytko, Shadi Abdar Esfahani, Avinash R Kambadakone, Anthony Samir, Shaunagh McDermott, Liran Domachevsky, Stephan Ursprung, Onofrio A Catalano
Neuroendocrine neoplasms are a heterogeneous group of gastrointestinal and lung tumors. Their diverse clinical manifestations, variable locations, and heterogeneity present notable diagnostic challenges. This article delves into the imaging modalities vital for their detection and characterization. Computed tomography is essential for initial assessment and staging. At the same time, magnetic resonance imaging (MRI) is particularly adept for liver, pancreatic, osseous, and rectal imaging, offering superior soft tissue contrast...
April 24, 2024: Journal of Computer Assisted Tomography
https://read.qxmd.com/read/38655905/short-term-biological-toxicity-prediction-of-177-lu-lutetium-oxodotreotide-an-original-retrospective-analysis
#10
JOURNAL ARTICLE
Julien Dubois, Guillaume Tosato, Philippe Garrigue, David Taieb, Benjamin Guillet, Vincent Nail
Introduction: [177 Lu]Lutetium (Lu)-oxodotreotide is a radiopharmaceutical drug used as peptide receptor radionuclide therapy (PRRT) for somatostatin receptor-expressing neuroendocrine neoplasms. It provides an additional effective alternative treatment for these rare cancers. Although well tolerated, its safety profile must continue to be characterized to support its use as a first-line treatment or for additional cycles. This study aims to evaluate factors associated with the occurrence of [177 Lu]Lu-oxodotreotide induced short-term toxicity...
April 24, 2024: Cancer Biotherapy & Radiopharmaceuticals
https://read.qxmd.com/read/38651961/-cancer-associated-cachexia-an-unresolved-disease
#11
JOURNAL ARTICLE
Jean Bastin
Cachexia is a systemic wasting condition associated to advanced phases of many cancers, which contributes to significant morbidity and mortality. It is mainly characterized by involuntary weight loss due to muscle wasting often associated with loss of adipose tissue, possibly leading to inanition and death, without treatment to date. Symptomatology covers a complex array of disorders (fatigue, inflammation, pain, anorexia, depression) related to multisystemic impairments progressively affecting numerous organs and tissues (muscle, adipose tissue, brain, immune system, gastrointestinal tract)...
April 2024: Médecine Sciences: M/S
https://read.qxmd.com/read/38638202/unusual-upper-gastrointestinal-bleeding-due-to-a-neuroendocrine-tumor-arising-in-meckel-diverticulum
#12
Katherine Elizabeth Eberly, Jasmin Martinez, Nitin Sardana
Meckel diverticulum is the most common congenital variation of the gastrointestinal tract arising from incomplete obliteration of the vitelline duct during gestation. In most cases, individuals are asymptomatic. This is a case of a 38-year-old patient with hematochezia in whom Meckel diverticulum was diagnosed. A mass was identified within the diverticulum. Histopathological and immunohistochemical studies revealed a well-differentiated neuroendocrine tumor. The development of tumors in Meckel diverticulum is rare, and when identified, only 0...
April 2024: ACG Case Reports Journal
https://read.qxmd.com/read/38635098/multiple-gastric-neuroendocrine-tumors-in-a-patient-with-parietal-cell-dysfunction-and-adenosine-triphosphatase-h-k-transporting-subunit-alpha-gene-variant
#13
JOURNAL ARTICLE
Yu Sasaki, Yasuhiko Abe, Ken Haruma, Hidenori Sato, Makoto Yagi, Naoko Mizumoto, Yusuke Onozato, Minami Ito, Takahiro Watabe, Yoshiyuki Ueno
A 47-year-old woman presented with multiple gastric tumors, each up to 10 mm in diameter, in the gastric body and fundus without mucosal atrophy. White spots and numerous transparent, light-brownish, small, and rounded spots were observed in the background gastric mucosa. Biopsy specimens obtained from the tumors revealed gastric neuroendocrine tumors. The patient exhibited hypergastrinemia and achlorhydria and tested negative for serum parietal cell antibody, intrinsic factor antibody, and Helicobacter pylori infection...
April 18, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38634903/gastric-neuroendocrine-tumor-presenting-with-carcinoid-syndrome
#14
JOURNAL ARTICLE
Luís Miguel Relvas, Tânia Gago, Francisco Velasco, Sónia Barros, Isabel Carvalho, Bruno Peixe
Carcinoid tumors are rare neoplasms, most frequently found in the gastrointestinal tract, responsible for the production of neuroendocrine mediators. Carcinoid syndrome is even rarer and consists of a set of symptoms characteristic of the release of these mediators into the systemic circulation. We present an interesting case of a patient with carcinoid syndrome as a late manifestation of a gastric neuroendocrine tumor with, highlighting the importance of knowing how to identify the carcinoid syndrome.
April 18, 2024: Revista Española de Enfermedades Digestivas
https://read.qxmd.com/read/38634006/metastatic-type-1-low-grade-gastric-neuroendocrine-tumor-treated-with-peptide-receptor-radionuclide-therapy-in-a-young-adult-a-case-report
#15
JOURNAL ARTICLE
Elisabetta Dell'Unto, Maria Rinzivillo, Gianluca Esposito, Elsa Iannicelli, Daniela Prosperi, Francesco Panzuto, Bruno Annibale
No abstract text is available yet for this article.
2024: Gastroenterology Report
https://read.qxmd.com/read/38629640/clinicopathological-characteristics-survival-and-prognostic-factors-in-gastrointestinal-large-cell-neuroendocrine-carcinoma-a-retrospective-cohort-study
#16
JOURNAL ARTICLE
Lele Chang, Xuemei Zhang, Jiaxin Li, Qingwei Li
BACKGROUND: Gastrointestinal large cell neuroendocrine carcinoma (GILCNEC) has a low incidence but high malignancy and poor prognosis.The main purpose of this study was to thoroughly investigate its clinicopathological features, survival and prognostic factors. METHODS: Information on patients with GILCNEC was extracted from the Surveillance, Epidemiology, and End Result program, and prognostic factors were analyzed by analyzing clinicopathological data and survival functions...
April 17, 2024: American Journal of Clinical Oncology
https://read.qxmd.com/read/38617746/advancements-in-medical-treatment-for-pancreatic-neuroendocrine-tumors-a-beacon-of-hope
#17
REVIEW
Somdatta Giri, Jayaprakash Sahoo
This editorial highlights the remarkable advancements in medical treatment strategies for pancreatic neuroendocrine tumors (pan-NETs), emphasizing tailored approaches for specific subtypes. Cytoreductive surgery and somatostatin analogs (SSAs) play pivotal roles in managing tumors, while palliative options such as molecular targeted therapy, peptide receptor radionuclide therapy, and chemotherapy are reserved for SSA-refractory patients. Gastrinomas, insulinomas, glucagonomas, carcinoid tumors and VIPomas necessitate distinct thera-peutic strategies...
March 28, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38615503/imaging-of-pediatric-gastrointestinal-tumors-a-tertiary-center-experience-over-19%C3%A2-years
#18
JOURNAL ARTICLE
Mareen S Kraus, Swathi Selvam, Iram Siddiqui, Jeanette A Reyes, Govind B Chavhan
PURPOSE: Gastrointestinal tract (GIT) tumors in children are rare and there is a scarcity of data on their imaging features. The purpose of this study was to determine thefrequency of various GIT tumor types in children and to identify key imaging characteristics. METHODS: This retrospective, single-center study was approved by the local ethics committee. Children with histologically proven GIT tumours (malignantand benign) who had imaging available on the institutional PACS between May 1, 2000 and Dec 31, 2019 were included...
April 10, 2024: European Journal of Radiology
https://read.qxmd.com/read/38610738/proton-pump-inhibitors-and-cancer-risk-a-comprehensive-review-of-epidemiological-and-mechanistic-evidence
#19
REVIEW
Ibrahim O Sawaid, Abraham O Samson
Background: Proton pump inhibitors (PPIs) are commonly prescribed long-acting drugs used to treat acid reflux, gastroesophageal reflux disease (GERD), and peptic ulcers. Recently, concerns have been raised about their safety, particularly due to the association between long-term PPI use and cancer development. Multiple comprehensive studies have consistently suggested a noteworthy link between prolonged PPI usage and an increased risk of developing gastric, esophageal, colorectal, and pancreatic cancers, yet the precise underlying mechanism remains elusive...
March 28, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38605236/author-correction-potent-suppression-of-neuroendocrine-tumors-and-gastrointestinal-cancers-by-cdh17car-t-cells-without-toxicity-to-normal-tissues
#20
Zijie Feng, Xin He, Xuyao Zhang, Yuan Wu, Bowen Xing, Alison Knowles, Qiaonan Shan, Samuel Miller, Taylor Hojnacki, Jian Ma, Bryson W Katona, Terence P F Gade, Don L Siegel, Jörg Schrader, David C Metz, Carl H June, Xianxin Hua
No abstract text is available yet for this article.
April 11, 2024: Nature Cancer
keyword
keyword
17574
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.